Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol vs Placebo in Iron Deficiency Anemia
NCT01114139Phase 3Completed
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- Jun 2010
- Primary completion
- Feb 2012
- Modality
- Nanoparticles, Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Ferumoxytol with Placebo (2 arms). Primary endpoint: Participants Who Achieved A >=2.0 g/dL Increase In Hemoglobin At Any Time From Baseline To Week 5. Started Jun 2010; status: completed.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01114139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01114139.